{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:34:25Z","timestamp":1775583265438,"version":"3.50.1"},"reference-count":172,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T00:00:00Z","timestamp":1343692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1136\/annrheumdis-2012-201940","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T03:32:15Z","timestamp":1343791935000},"page":"1771-1782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":850,"title":["Joint European League Against Rheumatism and European Renal Association\u2013European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis"],"prefix":"10.1016","volume":"71","author":[{"given":"George K","family":"Bertsias","sequence":"first","affiliation":[]},{"given":"Maria","family":"Tektonidou","sequence":"additional","affiliation":[]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Aringer","sequence":"additional","affiliation":[]},{"given":"Ingeborg","family":"Bajema","sequence":"additional","affiliation":[]},{"given":"Jo H M","family":"Berden","sequence":"additional","affiliation":[]},{"given":"John","family":"Boletis","sequence":"additional","affiliation":[]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"D\u00f6rner","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[]},{"given":"Franco","family":"Ferrario","sequence":"additional","affiliation":[]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[]},{"given":"Frederic A","family":"Houssiau","sequence":"additional","affiliation":[]},{"given":"John P A","family":"Ioannidis","sequence":"additional","affiliation":[]},{"given":"David A","family":"Isenberg","sequence":"additional","affiliation":[]},{"given":"Cees G M","family":"Kallenberg","sequence":"additional","affiliation":[]},{"given":"Liz","family":"Lightstone","sequence":"additional","affiliation":[]},{"given":"Stephen D","family":"Marks","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Moroni","sequence":"additional","affiliation":[]},{"given":"Irmgard","family":"Neumann","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[]},{"given":"Argyre","family":"Starra","sequence":"additional","affiliation":[]},{"given":"Vladimir","family":"Tesar","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Vasconcelos","sequence":"additional","affiliation":[]},{"given":"Ronald F","family":"van Vollenhoven","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Zakharova","sequence":"additional","affiliation":[]},{"given":"Marion","family":"Haubitz","sequence":"additional","affiliation":[]},{"given":"Caroline","family":"Gordon","sequence":"additional","affiliation":[]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[]},{"given":"Dimitrios T","family":"Boumpas","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201940_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0961203309358901","article-title":"Isolated pyuria in systemic lupus erythematosus","volume":"19","author":"Appenzeller","year":"2010","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1191\/096120301678646164","article-title":"Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus","volume":"10","author":"Rahman","year":"2001","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib5","first-page":"163","article-title":"Lupus nephritis: clinical and pathological correlation","volume":"62","author":"Leaker","year":"1987","journal-title":"Q J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/art.1780330708","article-title":"Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients","volume":"33","author":"Nossent","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib7","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.21929","article-title":"Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus","volume":"54","author":"Tisseverasinghe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/art.22449","article-title":"Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis","volume":"56","author":"Grootscholten","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ki.2010.525","article-title":"Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus","volume":"79","author":"Reich","year":"2011","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0961203307084167","article-title":"Estimating renal function in lupus nephritis: comparison of the modification of diet in renal disease and Cockcroft Gault equations","volume":"16","author":"Kasitanon","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ki.1988.257","article-title":"Serial assessment of glomerular filtration rate in lupus nephropathy","volume":"34","author":"Petri","year":"1988","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib12","first-page":"779","article-title":"The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature","volume":"72","author":"Esdaile","year":"1989","journal-title":"Q J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/ndt\/gfk073","article-title":"Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up","volume":"21","author":"Moroni","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib14","first-page":"1563","article-title":"Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure","volume":"33","author":"Faurschou","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/00000478-200608000-00015","article-title":"Interobserver reproducibility and application of the ISN\/RPS classification of lupus nephritis-a UK-wide study","volume":"30","author":"Furness","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/annrheumdis-2012-201940_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfm555","article-title":"Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis","volume":"23","author":"Grootscholten","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib18","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/archinte.1985.00360110066018","article-title":"Tubulointerstitial renal disease in systemic lupus erythematosus","volume":"145","author":"O'Dell","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib19","first-page":"907","article-title":"Predictors of one year outcome in lupus nephritis: the importance of renal biopsy","volume":"81","author":"Esdaile","year":"1991","journal-title":"Q J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib20","first-page":"1620","article-title":"High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients","volume":"10","author":"Austin","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1046\/j.1523-1755.2000.00272.x","article-title":"A new morphologic index for the evaluation of renal biopsies in lupus nephritis","volume":"58","author":"Hill","year":"2000","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/s10165-006-0545-8","article-title":"Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis","volume":"17","author":"Ogawa","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-199709000-00003","article-title":"Renal vascular lesions in lupus nephritis","volume":"76","author":"Descombes","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/annrheumdis-2012-201940_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000167563","article-title":"The importance of sample size in the interpretation of the renal biopsy","volume":"8","author":"Corwin","year":"1988","journal-title":"Am J Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-198407000-00003","article-title":"Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors","volume":"63","author":"Magil","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/annrheumdis-2012-201940_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/096120330000900705","article-title":"Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis","volume":"9","author":"Nossent","year":"2000","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome","volume":"25","author":"Austin","year":"1984","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7326\/0003-4819-96-6-718","article-title":"The information content from renal biopsy in systemic lupus erythematosus","volume":"96","author":"Whiting-O'Keefe","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-96-6-723","article-title":"Recognition of information in renal biopsies of patients with lupus nephritis","volume":"96","author":"Whiting-O'Keefe","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","article-title":"Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis","volume":"62","author":"Faurschou","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/annrheumdis-2012-201940_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/03009740903456300","article-title":"Minimal mesangial lupus nephritis: a systematic review","volume":"39","author":"Mok","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/rheumatology\/ken019","article-title":"Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions","volume":"47","author":"Hiramatsu","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib33","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/art.10142","article-title":"Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies","volume":"46","author":"Illei","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib35","doi-asserted-by":"crossref","first-page":"355e25","DOI":"10.1016\/j.amjmed.2005.08.045","article-title":"Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide","volume":"119","author":"Mok","year":"2006","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.03280807","article-title":"Value of a complete or partial remission in severe lupus nephritis","volume":"3","author":"Chen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib37","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.20364","article-title":"Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis","volume":"50","author":"Mok","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib38","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/ki.1996.528","article-title":"\u2018Nephritic flares\u2019 are predictors of bad long-term renal outcome in lupus nephritis","volume":"50","author":"Moroni","year":"1996","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib39","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/ndt\/gfm245","article-title":"The long-term outcome of 93 patients with proliferative lupus nephritis","volume":"22","author":"Moroni","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib40","first-page":"1198","article-title":"Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?","volume":"29","author":"Ward","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0961203308089408","article-title":"Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study","volume":"17","author":"Wang","year":"2008","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/0003-4819-135-4-200108210-00009","article-title":"Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis","volume":"135","author":"Illei","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib45","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib46","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib47","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib48","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib49","first-page":"341","article-title":"Mycophenolic acid formulations in adult renal transplantation\u2014update on efficacy and tolerability","volume":"5","author":"Golshayan","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1136\/annrheumdis-2012-201940_bib50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/TP.0b013e3181ca860d","article-title":"Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients","volume":"89","author":"Sollinger","year":"2010","journal-title":"Transplantation"},{"key":"10.1136\/annrheumdis-2012-201940_bib51","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1177\/0961203311418269","article-title":"Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis","volume":"20","author":"Zeher","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib52","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib53","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2009.412","article-title":"Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis","volume":"77","author":"Radhakrishnan","year":"2010","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/rheumatology\/kep346","article-title":"Influence of race\/ethnicity on response to lupus nephritis treatment: the ALMS study","volume":"49","author":"Isenberg","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib56","first-page":"1694","article-title":"Hypertension increases the risk of renal deterioration in systemic lupus erythematosus","volume":"20","author":"Ginzler","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0272-6386(12)80177-6","article-title":"The prognosis of lupus nephritis in African-Americans: a retrospective analysis","volume":"24","author":"Bakir","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","volume":"340","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201940_bib59","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.ki.5001630","article-title":"Azathioprine\/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial","volume":"70","author":"Grootscholten","year":"2006","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib60","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archinte.1971.00310220074008","article-title":"Effect of azathioprine on renal histology and function in lupus nephritis","volume":"128","author":"Shelp","year":"1971","journal-title":"Arch Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib61","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203302lu243oa","article-title":"Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications","volume":"11","author":"Badsha","year":"2002","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1191\/0961203304lu510xx","article-title":"Low-dose pulse methylprednisolone is an effective therapy for severe SLE flares","volume":"13","author":"Kong","year":"2004","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2004050350","article-title":"Glomerular podocytopathy in patients with systemic lupus erythematosus","volume":"16","author":"Kraft","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/0961203306lu2264oa","article-title":"Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis","volume":"15","author":"Han","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00467-004-1707-6","article-title":"Renal tubular dysfunction in children with systemic lupus erythematosus","volume":"20","author":"Marks","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000168266","article-title":"Tubular dysfunction in proliferative lupus nephritis","volume":"11","author":"ter Borg","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib67","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1136\/ard.2010.131995","article-title":"Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib68","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib69","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2215\/CJN.02271205","article-title":"A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years","volume":"1","author":"Moroni","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib70","first-page":"147","article-title":"Cyclosporine treatment of lupus membranous nephropathy","volume":"42","author":"Radhakrishnan","year":"1994","journal-title":"Clin Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib71","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0272-6386(12)80263-0","article-title":"Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group","volume":"21","author":"Schwartz","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-125-7-199610010-00003","article-title":"Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial","volume":"125","author":"Gourley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-003-1133-1","article-title":"Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children","volume":"18","author":"Filler","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.2010.170","article-title":"Pharmacokinetics of mycophenolic acid in severe lupus nephritis","volume":"78","author":"Lertdumrongluk","year":"2010","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib76","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/art.27495","article-title":"Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil","volume":"62","author":"Zahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib77","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/41.8.876","article-title":"Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents","volume":"41","author":"Karim","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib78","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/rheumatology\/40.8.863","article-title":"Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone","volume":"40","author":"Moss","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.autrev.2011.10.009","article-title":"Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts","volume":"11","author":"Diaz-Lagares","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2012-201940_bib80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12016-010-8205-3","article-title":"Rituximab therapy in lupus nephritis: current clinical evidence","volume":"40","author":"Ramos-Casals","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/annrheumdis-2012-201940_bib81","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1093\/ndt\/gfq322","article-title":"Long-term outcomes\u2013mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases","volume":"25","author":"Cortes-Hernandez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib82","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/0961203310366573","article-title":"Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis","volume":"19","author":"Lee","year":"2010","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib83","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-75-2-165","article-title":"Cyclophosphamide in lupus nephritis: a controlled trial","volume":"75","author":"Steinberg","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0049-0172(00)80018-9","article-title":"Intravenous immunoglobulin treatment of lupus nephritis","volume":"29","author":"Levy","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib85","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1744-9987.1997.tb00057.x","article-title":"Plasmapheresis in the treatment of rapidly progressive glomerulonephritis","volume":"1","author":"Harada","year":"1997","journal-title":"Ther Apher"},{"key":"10.1136\/annrheumdis-2012-201940_bib86","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2004.029660","article-title":"IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study","volume":"64","author":"Stummvoll","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib87","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ndt\/gfr239","article-title":"Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity","volume":"27","author":"Stummvoll","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib88","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/ard.2005.044248","article-title":"Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial","volume":"65","author":"Tam","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib89","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus Atherosclerosis Prevention Study (LAPS)","volume":"70","author":"Petri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib90","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/rheumatology\/ken208","article-title":"Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus\u2013results from LUMINA (LIX): a multiethnic US cohort","volume":"47","author":"Duran-Barragan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib91","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1191\/0961203305lu2076oa","article-title":"Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy","volume":"14","author":"Kanda","year":"2005","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib92","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1191\/0961203305lu2249oa","article-title":"Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria","volume":"14","author":"Tse","year":"2005","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib93","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.21039","article-title":"Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual","volume":"52","author":"Fessler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib94","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib95","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib96","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1136\/annrheumdis-2012-201940_bib97","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib98","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib99","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2009.117200","article-title":"European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies","volume":"69","author":"Mosca","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.22667","article-title":"High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients","volume":"57","author":"Nath","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib101","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/art.1780240503","article-title":"Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy","volume":"24","author":"Nyberg","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib102","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ki.2009.344","article-title":"A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis","volume":"76","author":"Fine","year":"2009","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib103","doi-asserted-by":"crossref","first-page":"c177","DOI":"10.1159\/000232599","article-title":"Random spot urine protein\/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients","volume":"113","author":"Hebert","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1136\/annrheumdis-2012-201940_bib104","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/rheumatology\/kel360","article-title":"Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis","volume":"46","author":"Leung","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0272-6386(95)90488-3","article-title":"Relationship between appearance of urinary red blood cell\/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus","volume":"26","author":"Hebert","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib106","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/ard.2008.094508","article-title":"Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis","volume":"68","author":"Moroni","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib107","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib108","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.1780390304","article-title":"Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail","volume":"39","author":"Esdaile","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib109","first-page":"50","article-title":"Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study","volume":"29","author":"Ghirardello","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1191\/0961203306lu2308oa","article-title":"Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis","volume":"15","author":"Jaekell","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib111","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/ard.2006.065425","article-title":"A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine\/methylprednisolone","volume":"66","author":"Grootscholten","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib112","first-page":"1538","article-title":"Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies","volume":"33","author":"Gutierrez-Adrianzen","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib113","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.trsl.2010.07.009","article-title":"Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus","volume":"156","author":"Mok","year":"2010","journal-title":"Transl Res"},{"key":"10.1136\/annrheumdis-2012-201940_bib114","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semnephrol.2011.06.009","article-title":"Lupus nephritis: role of antinucleosome autoantibodies","volume":"31","author":"van der Vlag","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib115","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/art.1780170602","article-title":"A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis","volume":"17","author":"Steinberg","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib116","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","article-title":"Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages","volume":"59","author":"Hill","year":"2001","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib117","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1046\/j.1523-1755.2002.00357.x","article-title":"Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy","volume":"61","author":"Hill","year":"2002","journal-title":"Kidney Int"},{"key":"10.1136\/annrheumdis-2012-201940_bib118","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0272-6386(99)70082-X","article-title":"Clinical and prognostic value of serial renal biopsies in lupus nephritis","volume":"34","author":"Moroni","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib119","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM198408233110802","article-title":"Effect of treatment on the evolution of renal abnormalities in lupus nephritis","volume":"311","author":"Balow","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bmj.290.6462.126","article-title":"Why do patients with lupus nephritis die?","volume":"290","author":"Correia","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1136\/annrheumdis-2012-201940_bib121","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ndt\/gfi153","article-title":"Thrombotic microangiopathy in United States long-term dialysis patients","volume":"21","author":"Perkins","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib122","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/ndt\/gfi060","article-title":"Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis","volume":"20","author":"Siu","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000266480","article-title":"Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes","volume":"32","author":"Weng","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"10.1136\/annrheumdis-2012-201940_bib124","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(90)90295-O","article-title":"Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE","volume":"89","author":"Nossent","year":"1990","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1159\/000089708","article-title":"Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort","volume":"25","author":"Ribeiro","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib126","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9343(87)90888-6","article-title":"Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis","volume":"83","author":"Rodby","year":"1987","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib127","first-page":"1520","article-title":"Factors associated with active systemic lupus erythematosus after endstage renal disease","volume":"25","author":"Szeto","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib128","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2169\/internalmedicine.40.598","article-title":"Analysis of lupus activity in end-stage renal disease treated by hemodialysis","volume":"40","author":"Okano","year":"2001","journal-title":"Intern Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000167981","article-title":"Poor prognosis in end-stage lupus nephritis due to nonautologous vascular access site associated septicemia and lupus flares","volume":"9","author":"Sires","year":"1989","journal-title":"Am J Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib130","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/ndt\/gfn429","article-title":"Renal replacement therapy in lupus nephritis","volume":"23","author":"Rietveld","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib131","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.tp.0000235740.56573.c6","article-title":"Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database","volume":"82","author":"Bunnapradist","year":"2006","journal-title":"Transplantation"},{"key":"10.1136\/annrheumdis-2012-201940_bib132","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/ndt\/gfm459","article-title":"The outcome of renal transplantation among systemic lupus erythematosus patients","volume":"22","author":"Chelamcharla","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000168816","article-title":"Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases","volume":"15","author":"el-Shahawy","year":"1995","journal-title":"Am J Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib134","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.TP.0000053750.59630.83","article-title":"Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare","volume":"75","author":"Goral","year":"2003","journal-title":"Transplantation"},{"key":"10.1136\/annrheumdis-2012-201940_bib135","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.transproceed.2008.02.045","article-title":"Systemic lupus erythematosus after renal transplantation: is complement a good marker for graft survival?","volume":"40","author":"Signori Baracat","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1136\/annrheumdis-2012-201940_bib136","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1681\/ASN.2009101093","article-title":"Recurrence of lupus nephritis after kidney transplantation","volume":"21","author":"Contreras","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0049-0172(97)80033-9","article-title":"Outcome of renal transplantation in systemic lupus erythematosus","volume":"27","author":"Stone","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib138","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-0012.2007.00781.x","article-title":"Factors affecting kidney-transplant outcome in recipients with lupus nephritis","volume":"22","author":"Tang","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib139","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.transproceed.2011.08.092","article-title":"Preemptive kidney transplantation in systemic lupus erythematosus","volume":"43","author":"Naveed","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1136\/annrheumdis-2012-201940_bib140","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2005.01.038","article-title":"The long-term prognosis of renal transplantation in patients with lupus nephritis","volume":"45","author":"Moroni","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib141","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","article-title":"Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus","volume":"34","author":"Stone","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib142","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00007890-200004150-00023","article-title":"Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study","volume":"69","author":"Vaidya","year":"2000","journal-title":"Transplantation"},{"key":"10.1136\/annrheumdis-2012-201940_bib143","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.1998.tb00995.x","article-title":"Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies","volume":"12","author":"Vaidya","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib144","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.24776","article-title":"Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution","volume":"60","author":"Burgos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib145","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/ard.2009.122796","article-title":"Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study","volume":"69","author":"Norby","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib146","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome","volume":"50","author":"Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib147","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/rheumatology\/kep152","article-title":"Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies","volume":"48","author":"Galindo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201940_bib148","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0961203308093460","article-title":"IgA antiphospholipid antibodies are an independent risk factor for thromboses","volume":"17","author":"Shen","year":"2008","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib149","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2736","article-title":"Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases","volume":"11","author":"Zheng","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2012-201940_bib150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1440-1797.2007.00792.x","article-title":"Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies","volume":"12","author":"Cheunsuchon","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1136\/annrheumdis-2012-201940_bib151","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib152","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","author":"The Canadian Hydroxychloroquine Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib153","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib154","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2012-201940_bib155","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0961203310397967","article-title":"Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus","volume":"20","author":"Kwok","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib156","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2012-201940_bib157","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0897.2005.00263.x","article-title":"Class III\u2013IV proliferative lupus nephritis and pregnancy: a study of 42 cases","volume":"53","author":"Carmona","year":"2005","journal-title":"Am J Reprod Immunol"},{"key":"10.1136\/annrheumdis-2012-201940_bib158","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201940_bib159","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-9343(86)90251-2","article-title":"Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia","volume":"81","author":"Buyon","year":"1986","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2012-201940_bib160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ard.60.6.599","article-title":"Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre","volume":"60","author":"Huong","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201940_bib161","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2012-201940_bib162","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0961203311416694","article-title":"Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis","volume":"20","author":"Livingston","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib163","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1191\/096120399678840828","article-title":"Risk factors for hypercreatinemia in patients with systemic lupus erythematosus","volume":"8","author":"Rzany","year":"1999","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2012-201940_bib164","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.11205","article-title":"Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study","volume":"49","author":"Ravelli","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.23204","article-title":"Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus","volume":"58","author":"Brunner","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib166","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpeds.2007.09.019","article-title":"Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study","volume":"152","author":"Hiraki","year":"2008","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2012-201940_bib167","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.24091","article-title":"Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus","volume":"61","author":"Hersh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201940_bib168","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jpeds.2009.12.022","article-title":"Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: results from a multicenter study","volume":"156","author":"Taddio","year":"2010","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2012-201940_bib169","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(00)02627-1","article-title":"Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study","volume":"356","author":"Traynor","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201940_bib170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/rheumatology\/37.2.217","article-title":"Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria","volume":"37","author":"Fu","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201940_bib171","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pedhc.2007.07.006","article-title":"Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil","volume":"22","author":"Lau","year":"2008","journal-title":"J Pediatr Health Care"},{"key":"10.1136\/annrheumdis-2012-201940_bib172","first-page":"1491","article-title":"Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide","volume":"34","author":"Urowitz","year":"2007","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:43:29Z","timestamp":1739522609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724186256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":172,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0003496724186256"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201940","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint European League Against Rheumatism and European Renal Association\u2013European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}